Evidence map›Paper›PMID 28466358›Full record

ArticleBrain structure & function2017

Differential surface density and modulatory effects of presynaptic GABA

Sam A Booker, Daniel Althof, Claudius E Degro, Masahiko Watanabe, Ákos Kulik, Imre Vida

Open access · hybridAbstract read
In one paragraph

Article in Brain structure & function, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Presynaptic GABAeLife · 2020
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Sam A BookerInstitute for Integrative Neuroanatomy, Neurocure Cluster of Excellence, Charité-Universitätmedizin Berlin, 10115, Berlin, Germany. sbooker@exseed.ed.ac.uk.
Daniel AlthofInstitute of Physiology, University of Freiburg, Freiburg, Germany.
Claudius E DegroInstitute for Integrative Neuroanatomy, Neurocure Cluster of Excellence, Charité-Universitätmedizin Berlin, 10115, Berlin, Germany.
Masahiko WatanabeDepartment of Anatomy, Graduate School of Medicine, Hokkaido University, Sapporo, 0608638, Japan.
Ákos KulikInstitute of Physiology, University of Freiburg, Freiburg, Germany.
Imre VidaInstitute for Integrative Neuroanatomy, Neurocure Cluster of Excellence, Charité-Universitätmedizin Berlin, 10115, Berlin, Germany. imre.vida@charite.de.ORCID http://orcid.org/0000-0003-3214-2233
Charité - Universitätsmedizin Berlin · DEUniversity of Freiburg · DEHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The perisomatic domain of cortical neurons is under the control of two major GABAergic inhibitory interneuron types: regular-spiking cholecystokinin (CCK) basket cells (BCs) and fast-spiking parvalbumin (PV) BCs. CCK and PV BCs are different not only in their intrinsic physiological, anatomical and molecular characteristics, but also in their presynaptic modulation of their synaptic output. Most GABAergic terminals are known to contain GABA

Indexed as

AnimalsCholecystokininHippocampusInhibitory Postsynaptic PotentialsNeural InhibitionParvalbuminsPresynaptic TerminalsPyramidal CellsRats, TransgenicRats, WistarReceptor, Cannabinoid, CB1Receptor, Muscarinic M2Receptors, GABA-BSynapsesCholecystokininParvalbuminsReceptor, Cannabinoid, CB1Receptor, Muscarinic M2Receptors, GABA-BElectron microscopeGABAergic interneuronsPresynaptic inhibitionShort-term plasticitySynaptic transmission

Identifiers

PMID28466358
PMCPMC5676818
OpenAlexW2610240891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.